← Back to Search

CBT-I for Alcoholism (STAR Trial)

N/A

Waitlist Available

Research Sponsored by University of Missouri-Columbia

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline to post-treatment (week 6) to follow-up (week 12)

Awards & highlights

STAR Trial Summary

This trial aims to see if adding CBT-I to outpatient alcohol and substance abuse treatment makes it more effective.

Eligible Conditions

Alcoholism
Substance Use Disorder
Insomnia

STAR Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline to post-treatment (week 6) to follow-up (week 12)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline to post-treatment (week 6) to follow-up (week 12)

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to post-treatment (week 6) to follow-up (week 12) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Recruitment

Retention

Treatment Satisfaction

Secondary outcome measures

Abstinence

Alcohol Problems

Alcohol or Other Drugs as Sleep Aids

+6 more

Other outcome measures

Executive Functioning - Attention

Executive Functioning - Delayed Discounting

Executive Functioning - Working Memory

+1 more

STAR Trial Design

1Treatment groups

Experimental Treatment

Group I: Cognitive-Behavioral Therapy for Insomnia (CBT-I)Experimental Treatment1 Intervention

Individual Cognitive Behavioral Therapy for Insomnia (CBT-I) delivered once a week for five (5) weeks

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

CBT-I

2018

Completed Phase 2

~620

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Missouri-ColumbiaLead Sponsor

361 Previous Clinical Trials

627,954 Total Patients Enrolled

2 Trials studying Alcoholism

392 Patients Enrolled for Alcoholism

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial actively accepting participants?

"As seen on clinicaltrials.gov, recruiting for this medical trial is currently underway; the listing was first posted in August of 2020 and amended most recently in October 2022."

Answered by AI

What is the upper limit for enrollment in this medical experiment?

"Affirmative. Clinicaltrials.gov provides evidence that this clinical trial, published at the start of August 2020, is actively seeking out participants. Forty patients are needed to be recruited from only one medical site."

Answered by AI

What are the primary objectives of this research endeavor?

"This medical trial will predominantly assess Retention at Post-Treatment (Week 6). Secondary metrics include Substance Use Days, Sleep Quality, and Abstinence. The former two are evaluated using the Timeline Followback technique for a 42 day period while Abstinence is determined through TLFB over the same duration."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Sleep Treatment for Addiction Recovery

Mary E Miller 2020. "Sleep Treatment for Addiction Recovery". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04198311.

All > Addiction